Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: Findings from the 52-week CANTATA-M study

Kaj Stenlöf, William T. Cefalu, Kyoung Ah Kim, Esteban Jodar, Maria Alba, Robert Edwards, Cindy Tong, William Canovatchel, Gary Meininger

Research output: Contribution to journal › Article › peer-review

148 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: Findings from the 52-week CANTATA-M study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science